Clinical Trials

Breathwork's Potential in Inducing Altered States of Consciousness

Exploratory study suggests breathwork may offer non-pharmacological ASC induction, akin to psychedelics.

Published June 10, 2026 Read 2 min 463 words By The Psychedelic Journal

Breathwork as a Gateway to Altered States

An exploratory study published in June 2026 has brought to light the potential of breathwork as a non-pharmacological method for inducing altered states of consciousness (ASCs). The study, titled 'The Airways to Alteration (A2A) Trial,' involved 24 healthy adults and compared the effects of high ventilation breathwork to body scan meditation. The primary outcomes focused on acute ASCs, including mystical experiences and emotional breakthroughs.

The findings suggest that breathwork can elicit experiences similar to those induced by psychedelics, such as oceanic boundlessness, visionary restructuralisation, and total mystical experience. These results were statistically significant, with p-values ranging from 0.007 to 0.038, indicating a robust effect size.

Mechanisms and Context

Breathwork involves controlled breathing techniques that increase the rate or depth of ventilation, potentially altering brain chemistry and function. This study's results align with anecdotal reports and smaller studies suggesting that breathwork can trigger ASC-like experiences without the need for psychoactive substances.

Participants in the study reported significant emotional breakthroughs and psychological insights, with follow-up assessments showing sustained behavioral changes and improvements in mood, stress, and anxiety levels. These outcomes suggest that breathwork could serve as a complementary or alternative approach to traditional psychedelic therapies.

Implications for Research and Policy

The study's findings advocate for further research into breathwork as a viable therapeutic tool. If validated by larger, confirmatory trials, breathwork could expand the toolkit available to clinicians treating conditions like depression, anxiety, and PTSD. This non-pharmacological approach may also appeal to individuals seeking ASC experiences without the legal and logistical complexities associated with psychedelic substances.

From a policy perspective, the integration of breathwork into therapeutic practices could necessitate new guidelines and training for practitioners. Regulatory bodies may need to consider how breathwork fits within existing frameworks for mental health interventions.

Risks and Unknowns

While the study presents promising results, several uncertainties remain. The long-term effects of repeated breathwork sessions are not yet well understood, and there may be risks associated with hyperventilation or other intense breathing techniques. Additionally, the study's small sample size and exploratory nature mean that findings should be interpreted cautiously.

Further research is needed to delineate the specific mechanisms through which breathwork induces ASCs and to identify any potential adverse effects. Researchers must also explore the variability of individual responses to breathwork, which could influence its efficacy and safety.

Looking Ahead

The A2A trial opens new avenues for consciousness research and therapeutic innovation. As interest in non-pharmacological interventions grows, breathwork could become a significant focus for future studies. Researchers and clinicians are encouraged to explore its potential, while policymakers consider the implications of integrating breathwork into mental health care systems.

Ultimately, the study underscores the importance of broadening the scope of ASC research beyond traditional psychedelics, potentially offering more accessible and diverse therapeutic options.

Primary source: https://openalex.org/W7164205844 — referenced for fact-checking; this analysis is independent commentary by the The Psychedelic Journal editorial team.
Found this useful?

Get tomorrow's briefing in your inbox

Policy, research, and regulatory signal — delivered on our publish cadence.

Free. No spam. Unsubscribe anytime.